These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6938016

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W, Wegner G.
    Scand J Urol Nephrol Suppl; 1980; 55():147-9. PubMed ID: 6938018
    [Abstract] [Full Text] [Related]

  • 3. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K.
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Estracyt treatment in prostatic neoplasms].
    Sander S.
    Tidsskr Nor Laegeforen; 1976 Jan 10; 96(1):27-8. PubMed ID: 1257949
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.
    Edsmyr F, Esposti PL, Andersson L.
    Scand J Urol Nephrol Suppl; 1980 Jan 10; 55():139-42. PubMed ID: 6938017
    [Abstract] [Full Text] [Related]

  • 10. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I.
    Orv Hetil; 1982 Jan 31; 123(5):287-9. PubMed ID: 7063244
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Use of Estracyt in cases of prostatic neoplasms].
    Wesolowski S, Czaplicki M, Cieślak A.
    Pol Przegl Chir; 1976 Jun 31; 48(6A):783-9. PubMed ID: 951325
    [No Abstract] [Full Text] [Related]

  • 13. Cancer of the prostate. Treating metastasis with estramustine phosphate.
    Hoeft RT, Jones AG.
    Am J Nurs; 1982 May 31; 82(5):829-30. PubMed ID: 6918193
    [No Abstract] [Full Text] [Related]

  • 14. [The phase IV studies with Estracyt in prostatic cancer].
    Ohhori T, Kubo T, Akasaka T, Funyu T, Yagihashi Y, Kudo T, Tsuchida S, Harada T, Sasaki S, Orikasa S.
    Hinyokika Kiyo; 1988 Aug 31; 34(8):1493-502. PubMed ID: 3057833
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC, Fosså SD, Kaalhus O.
    Tidsskr Nor Laegeforen; 1984 Oct 10; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of advanced carcinoma of the prostate with Estracyt (author's transl)].
    Nagel R, Kölln CP.
    Med Klin; 1976 Oct 08; 71(41):1724-8. PubMed ID: 824540
    [Abstract] [Full Text] [Related]

  • 17. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A, Lunglmayr G.
    Wien Med Wochenschr; 1983 Oct 08; 133(7):179-81. PubMed ID: 6868629
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M, Lutherer S, Terhorst B.
    Urologe A; 1981 Jul 08; 20(4):223-7. PubMed ID: 7196632
    [Abstract] [Full Text] [Related]

  • 19. Palliative treatment with oral Estracyte in disseminated prostatic carcinoma.
    Welvaart K.
    Arch Chir Neerl; 1975 Jul 08; 27(3):193-8. PubMed ID: 55103
    [Abstract] [Full Text] [Related]

  • 20. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A, Morvay J, Vécsei B.
    Orv Hetil; 1981 Apr 26; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.